M
Milan Milojevic
Researcher at Cardiovascular Institute of the South
Publications - 90
Citations - 5478
Milan Milojevic is an academic researcher from Cardiovascular Institute of the South. The author has contributed to research in topics: Percutaneous coronary intervention & Medicine. The author has an hindex of 20, co-authored 69 publications receiving 2148 citations. Previous affiliations of Milan Milojevic include Erasmus University Medical Center & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
2021 ESC/EACTS Guidelines for the management of valvular heart disease.
Alec Vahanian,Friedhelm Beyersdorf,Fabien Praz,Milan Milojevic,Stephan Baldus,Johann Bauersachs,Davide Capodanno,Lenard Conradi,Michele De Bonis,Ruggero De Paulis,Victoria Delgado,Nick Freemantle,Martine Gilard,Kristina H. Haugaa,Anders Jeppsson,Peter Jüni,Luc Pierard,Bernard Prendergast,J. Rafael Sadaba,Christophe Tribouilloy,Wojtek Wojakowski +20 more
Journal ArticleDOI
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
Stuart J. Head,Milan Milojevic,Joost Daemen,Jung-Min Ahn,Eric Boersma,Evald Høj Christiansen,Michael J. Domanski,Michael J. Domanski,Michael E. Farkouh,Michael E. Farkouh,Marcus Flather,Valentin Fuster,Mark A. Hlatky,Niels Ramsing Holm,Whady Hueb,Masoor Kamalesh,Young-Hak Kim,Timo H. Mäkikallio,Friedrich W. Mohr,Grigorios Papageorgiou,Seung-Jung Park,Alfredo E. Rodriguez,Joseph F. Sabik,Rodney H. Stables,Gregg W. Stone,Patrick W. Serruys,Arie Pieter Kappetein +26 more
TL;DR: CABG had a mortality benefit over PCI in patients with multivessel disease, particularly those with diabetes and higher coronary complexity, and no benefit for CABG over PCI was seen in Patients with left main disease.
Journal ArticleDOI
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
Daniel J F M Thuijs,A. Pieter Kappetein,Patrick W. Serruys,Friedrich-Wilhelm Mohr,Marie-Claude Morice,Michael J. Mack,David R. Holmes,Nick Curzen,Piroze M. Davierwala,Thilo Noack,Milan Milojevic,Keith D. Dawkins,Bruno R. da Costa,Bruno R. da Costa,Peter Jüni,Stuart J. Head,Filip Casselman,Bernard De Bruyne,Evald Høj Christiansen,Juan M. Ruiz-Nodar,Paul Vermeersch,Werner Schultz,Manel Sabaté,Giulio Guagliumi,Herko Grubitzsch,Karl Stangl,Olivier Darremont,M. Bentala,Peter den Heijer,István Préda,Robert C. Stoler,Tamás Szerafin,John K. Buckner,Myles S. Guber,Niels Verberkmoes,Ferdi Akca,Ted Feldman,Friedhelm Beyersdorf,Benny Drieghe,Keith G. Oldroyd,Geoff Berg,Anders Jeppsson,Kimberly Barber,Kevin Wolschleger,John Heiser,Pim van der Harst,Massimo A. Mariani,Hermann Reichenspurner,Christoffer Stark,Mika Laine,Paul C. Ho,John C. Chen,Richard Zelman,Phillip A. Horwitz,Andrzej Bochenek,Agata Krauze,Christina Grothusen,Dariusz Dudek,George Heyrich,Philippe Kolh,Victor Legrand,Pedro Coelho,Stephan Ensminger,Boris Nasseri,Richard Ingemansson,Goran Olivecrona,Javier Escaned,Reddy Guera,Sergio Berti,Alaide Chieffo,Nicholas Burke,Michael Mooney,Alvise Spolaor,Christian Hagl,Michael Nabauer,Maarten J. Suttorp,Ronald A. Stine,Thomas McGarry,Scott Lucas,Knut Endresen,Andrew Taussig,Kevin A. Accola,Umberto Canosi,Iván Horváth,Louis Cannon,John D. Talbott,Chris W. Akins,Robert S. Kramer,Michael Aschermann,William Killinger,Inga Narbute,Francesco Burzotta,Ad J.J.C. Bogers,Felix Zijlstra,Hélène Eltchaninoff,Jacques Berland,Giulio G. Stefanini,Ignacio Cruz Gonzalez,Uta C. Hoppe,Stefan Kiesz,Bartlomiej Gora,Anders Ahlsson,Matthias Corbascio,Thomas Bilfinger,Didier Carrié,Didier Tchetche,Karl-Eugen Hauptman,Elisabeth Ståhle,Stefan James,Sigrid Sandner,Günther Laufer,Irene Lang,Adam Witkowski,Vinod H. Thourani,Harry Suryapranata,Simon Redwood,Charles Knight,Philip MacCarthy,Adam de Belder,Adrian P. Banning,Anthony H. Gershlick +120 more
TL;DR: Ten years after percutaneous coronary intervention using first-generation paclitaxel-eluting stents with coronary artery bypass grafting in patients with de-novo three-vessel and left main coronary artery disease, there is no significant difference in all-cause death between PCI and CABG.
Journal ArticleDOI
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.
Domenico Pagano,Milan Milojevic,Michael I. Meesters,Umberto Benedetto,Daniel Bolliger,Christian von Heymann,Anders Jeppsson,Andreas Koster,Ruben L.J. Osnabrugge,Marco Ranucci,Hanne Berg Ravn,Alexander B.A. Vonk,Alexander Wahba,Christa Boer +13 more
Journal ArticleDOI
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.
Christa Boer,Michael I. Meesters,Milan Milojevic,Umberto Benedetto,Daniel Bolliger,Christian von Heymann,Anders Jeppsson,Andreas Koster,Ruben L.J. Osnabrugge,Marco Ranucci,Hanne Berg Ravn,Alexander B.A. Vonk,Alexander Wahba,Domenico Pagano +13 more
TL;DR: Authors/Task Force Members: Christa Boer (EACTA Chairperson) and Michael I. Meesters (Netherlands), Milan Milojevic (N Netherlands), Umberto Benedetto (UK), Daniel Bolliger (Switzerland), Christian von Heymann (Germany), Anders Jeppsson (Sweden), Andreas Koster (Germany).